Abstract:

Purpose: In this study, it was aimed to compare sexual dysfunctions, body mass index, liver function tests and prolactin levels in patients using long-acting antipsychotic drug forms (depot paliperidone palmitate, risperidone depot and zuclopenthixol depot). Materials and Methods: Patients diagnosed with schizophrenia and receiving long-acting antipsychotic therapy were included in this study. Demographic data form, Positive and Negative Syndrome Scale (PANSS), Calgary Depression in Schizophrenia Scale (CDSS), and Arizona Sexual Experiences Scale (ASEX) were administered to all participants. Venous blood samples were obtained from all participants to evaluate urea, creatinine, liver function tests, cholesterol and prolactin levels. Results: 95 patients were included in the study. Of those included, 79 (83.2%) were men and 16 (16.8%) were women. The mean age of all patients was 36.77±10.24 years. The mean body mass index was 27.06±4.95 kg/m2. There was no difference between the groups in terms of ASEX and CDSS scores. The prolactin level was found to be higher in patients using paliperidone depot than in patients using zuclopenthixol depot. Conclusion: According to our results, prolactin values that affect sexual functions should be considered in patients using long-acting antipsychotics, even if the patients do not show any symptoms. Further researches should be conducted on the effects of long-acting antipsychotic use on both prolactin values and other laboratory parameters.

Keywords: